Ads
related to: pfizer dermatology productsclinique.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Pfizer Inc's experimental drug to treat patients with moderate-to-severe atopic dermatitis met the main goals of improving symptoms in adult patients compared to a rival treatment from Regeneron ...
Pfizer's (PFE) JAK inhibitor candidates -- PF-06651600 and PF-06700841 -- demonstrate improvements in moderate to severe alopecia areata patients in a phase II study.
Glenmark Pharmaceuticals announced on January 31 that they have collaborated with Pfizer to launch Abrocitinib - which is an oral treatment for moderate-to-severe cases of atopic dermatitis or AD. [24] The drug which is originally developed by Pfizer will be sold under the brand name JABRYUS by Glenmark Pharmaceuticals. [25]
Wyeth discovered and initially developed the drug, and clinical development continued after that company was acquired by Pfizer.Fezakinumab, in combination with methotrexate, completed a phase II trial in rheumatoid arthritis, [3] but data were not released.
Pages in category "Drugs developed by Pfizer" The following 200 pages are in this category, out of approximately 240 total. This list may not reflect recent changes .
In 2011, Pfizer entered into a definitive agreement to acquire Ferrosan’s consumer healthcare business from Altor 2003 Fund GP Limited which includes dietary supplements and the Imedeen skincare range. [6] The BioMarine Complex in all US Imedeen tablets is a proprietary blend of fish proteins and polysaccharides. [5]
Ads
related to: pfizer dermatology productsclinique.com has been visited by 10K+ users in the past month